Skip to content

Analysis of the discontinuation rate and influencing factors of antidepressants based on patient-reported common adverse reactions

Analysis of the discontinuation rate and influencing factors of antidepressants based on patient-reported common adverse reactions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111836
Enrollment
Unknown
Registered
2025-11-06
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Interventions

Observational group:None

Sponsors

Beijing Anding Hospital ,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1.Inpatients or outpatients of Beijing Anding Hospital who have used antidepressant medications in the past year; 2.The types of antidepressant medications include SSRIs, SNRIs, SARIs, NASSAs, melatonin receptor agonists, and aminoketones, and adverse reactions have occurred; 3.Have a certain level of education and are able to understand and complete self-assessment questionnaires; 4.Aged 18 or older, with no gender restrictions; 5.Have signed the informed consent form for this study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1.Patients with severe neurological diseases or other serious physical illnesses, such as tumors, myocardial infarction, severe heart, liver, or renal insufficiency, etc.; 2.Patients with drug/alcohol dependence; 3.Patients with intellectual disabilities.

Design outcomes

Primary

MeasureTime frame
Discontinuation Rates Caused by Adverse Reactions to Frequently Used Antidepressant Medications;

Secondary

MeasureTime frame
Differences in the discontinuation rate caused by adverse reactions of different systems of antidepressants;Factors Influencing the Incidence of Antidepressant Discontinuation Rate Due to Various Adverse Drug Reactions;

Countries

China

Contacts

Public ContactZhai Qian

Beijing Anding Hospital ,Capital Medical University

maxicy@126.com+86 183 1105 8996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 18, 2026